01/14/14 - 07:49 AM EST
A panel of experts is debating the merits of Chelsea's drug as a treatment for a debilitating form of low blood pressure. Follow along with our live blog.
03/04/13 - 06:00 AM EST
An FDA panel's decision on the safety of calcitonin to treat osteoporosis will have a big impact on Unigene's stock price.
02/19/13 - 06:00 AM EST
TheStreet contributor Aafia Chaudhry says prior study results raise the risk of a bad outcome in Ziopharm's phase III sarcoma drug trial.
02/11/13 - 07:00 AM EST
Eteplirsen data are biased and flimsy, and FDA will ask for another clinical trial, says TheStreet contributor Aafia Chaudhry.
02/04/13 - 08:35 AM EST
New contributor Aafia Chaudhry explains why she believes Depomed's hot flash drug has no future.